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ABSTRACT 
Neonatal apnea is a serious condition that affects the health of infants, especially 
those born prematurely. To stimulate breathing, methylxanthine drugs, such as 
theophylline and caffeine, are administered to reverse this condition in humans and avoid 
the use of breathing-assistance equipment. These drugs cause stimulation of the central 
nervous system and the heart, however, both detrimental side effects in preterm infants. 
Antagonism of adenosine receptors is the proposed mechanism of methylxanthine action. 
Synthetic chemists have produced xanthine analogs with increased affinity for adenosine 
receptors that could lead to respiratory stimulation while reducing cardiostimulant effects. 
For this study, theophylline and 8-cyclopentyltheophylline (CPT), a potent adenosine Ai 
receptor antagonist, were used. It was predicted that low doses of CPT necessary to 
stimulate respiration would produce less stimulation in the heart rate in comparison to 
higher doses of theophylline. Heart rate in newborn ( 4-7 day old) rat pups was monitored 
using an electrocardiogram (ECG). Randomly assigned doses of theophylline, CPT, and 
saline (0.9% NaCl) control were administered. Theophylline produced a dose-related 
response in heart rate. The effects of C PT on heart rate were not statistically significant in 
the dose range tested. The highest dose of theophylline ( 40 mg/kg) produced a significant 
15% increase in heart rate. The highest of the dose of CPT (2560µg/kg) produced a 12% 
increase in heart rate above the pre-injection control heart rate. These data indicated that it 
might be possible to separate cardiac and respiratory stimulation of xanthine analogs 
based on selective antagonism of adenosine Ai receptors. 
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INTRODUCTION 
All newborns mammals may experience pauses in their breathing that can last six to 
ten seconds. This is expected because of their immaturity with breathing for the first few 
months of life, specifically, due to the immaturity of the rib cage, diaphragm, and 
respiratory muscles (Brouillette et al., 1990). Apnea occurs when these respiratory pauses 
last for more than 15 seconds and are followed by hypoxia and bradycardia (Schmidt et al., 
2006). The frequency and severity of apneic episodes is greatly increased in preterm 
infants because of their underdeveloped respiratory system (Brouillette et al., 1990) and 
central nervous system (Bancalari, 2006). Like adults, infants rely on the diaphragm in 
order to expand their lungs. However, the excess cartilage present in infant skeletal 
composition causes the diaphragm to be easily manipulated during inspiration, making 
breathing difficult (Brouillette et al., 1990). Often medical attention using a ventilation 
system is required to expand the lungs and remove the added stress from the cartilage on 
the diaphragm. To prevent the use of costly ventilation systems and surgeries, medical 
professionals seek the use of drug therapy with methylxanthines to stabilize respiration 
(Aranda et al., 1986; Schmidt et al, 2006). 
Methylxanthines are the most common types drugs used to combat recurrent apnea 
in neonates because of the stimulatory effect that they have on the respiratory center. The 
only methylxanthine drugs in use today are caffeine (1,3,7-trimethylxanthine) and 
theophylline (1,3-dimethylxanthine). Several efficacy studies have shown that theophylline 
decreases or abolishes apneic episodes in premature neonates (Aranda et al. 1986; 
Herlenius et al. 1997). The most important therapeutic action of methylxanthines in 
children and adults is their ability to relax tracheal and bronchial smooth muscle in order 
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to increase airflow (Rall, 1990; Undem, 2006). This bronchodilation likely contributes to 
theophylline's acute therapeutic effect in asthma as well as apnea (Undem, 2006). 
The proposed mechanism of action of methylxanthines is their ability to block 
adenosine Ai and Az receptors (Fredholm, 1980). Adenosine is a purine nucleoside that 
serves as an important regulator throughout the body, most notably in the cardiovascular 
and respiratory systems. Unlike other neurotransmitters that accumulate in vesicles or are 
released from nerve terminals, adenosine is an autocoid that is controlled by the hydrolysis 
of adenosine triphosphate (ATP; Fisone et al., 2004). Specifically, adenosine preserves the 
brain ATP levels and protects brain cells during hypoxia (Schmidt et al., 2006). Under 
normal conditions, the body maintains relatively low levels of free adenosine (Fis one et al., 
2004 ). During an apnea spell, however, there is a state of hypoxia causing adenosine 
accumulation in the brain to increase. The increased presence of free flowing adenosine 
inhibits respiratory drive. With the use of methylxanthines to block this hypoxia-induced 
apnea, respiratory neurons are stimulated resulting in an enhancement of minute 
ventilation, the volume of air inhaled or exhaled from the lungs per minute (Rall, 1985; 
Herlenius et al., 1997). 
While the respiratory stimulant effects of caffeine and theophylline are beneficial to 
premature infants who are at risk of apnea spells, they also have the ability to produce side 
effects including excitation of the central nervous system and heart (Aranda et al., 1986; 
Brouillette et al., 1990). These effects are undesirable for premature infants, as they may 
increase stress on the heart, increase irritability, and burn calories unnecessarily. 
Specifically, in the heart, adenosine regulates pacemaker activity through Ai and Az 
receptors (Mangoni and Barrere-Lemaire, 2004). As a result, the adenosine antagonistic 
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effects of methylxanthines may cause cardiovascular complications, such as increased heart 
rate, which in serious cases has progressed to supraventricular tachycardia or ventricular 
tachycardia. While methylxanthines increase oxygen consumption in preterm infants, they 
may diminish growth because of the adverse side effects on the cardiovascular system 
(Schmidt et al., 2006). 
In an effort to enhance the respiratory stimulant qualities of methylxanthines while 
preventing the negative cardiostimulant effects, synthetic chemists have been developing 
new xanthine analogs. Some of these xanthine analogs increase potency and solubility of 
methylxanthine drugs and some increase the specificity for the different adenosine 
receptor subtypes (Shamim et al, 1989). For this experiment, both theophylline and 






Figure 1. 1,3-dimethylxanthine (Theophylline) Figure. 2. 8-cyclopentyltheophylline (CPT) 
The addition of 8-cycloalkyl groups (e.g. cyclopentyl) to xanthines noticeably 
increases activity at Ai receptors, while increasing activity only moderately at A2 receptors, 
resulting in highly potent and selective Ai receptor antagonists (Shamim et al., 1989). The 
addition of a cyclopentyl group at the 8-position to theophylline has been found to greatly 
increase its potency and also selectivity as an adenosine Ai antagonist (Shamim et al., 
1989). In fact, CPT has 500 times greater affinity for adenosine Ai receptors and 100 times 
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greater affinity for Az receptors compared to theophylline (Shamim et al, 1989). This 
difference of affinity at Ai receptors suggests that there are differences in the potency of 
CPT as both a respiratory and cardiac stimulant if those effects were primarily caused by 
blocking Ai receptors. Understanding this relationship raises the possibility that chemists 
can increase specificity of xanthine drugs to antagonize receptors for respiratory 
stimulation, while leaving cardiostimulant receptors unaffected. 
The increased potency and specificity for adenosine Ai receptors would allow for 
smaller doses of CPT to be administered and could enhance respiratory stimulant effects, 
while decreasing the negative side effects, such as increased heart rate, that are associated 
with high doses of theophylline. A previous study in this lab showed CPT significantly 
stimulated respiration at 1280 µg/kg (Albers & McGilliard, 2012). A previous study of CPT 
in this lab attempted to show the cardiostimulant effects, but the study was complicated by 
unusual results for saline controls and did not show cardiostimulant effects of CPT 
(Workman & McGilliard, 2012). It was anticipated that the relationship between 
respiratory stimulant and cardiostimulant properties of xanthines would be better 
understood with improved CPT data. It was predicted that low doses of CPT necessary to 
stimulate respiration would produce less stimulation in the heart rate in comparison to 
higher doses of theophylline. This hypothesis was tested in newborn laboratory rats 
(Ra ttus norveg icus ). 
MATERIALS AND METHODS 
ANIMALS 
The subjects used for this experiment were newborn rats obtained from a breeding 
colony of inbred Sprague-Dawley laboratory rats at Eastern Illinois University in 
Arnold 7 
Charleston, Illinois. The colony was kept in a temperature controlled building within a 
separate air filtering system. Rats from 4-7 days old were studied, as the respiratory 
control mechanism at this age resembles that of preterm human infants. Each rat's mass, 
gender, age, and litter number were recorded. Each rat was used once. 
An electrocardiogram (ECG) is a recording of the electrical activity of the heart that 
results in a heartbeat. Five small skin (diameter = 5 mm) electrodes (E271-LP, In Vivo 
Metric) were placed on the ventral side of the newborn rat (Fig. 3). The wires of the ECG 
electrodes were secured to a 3 cm by 2 cm piece of rubber material that had been hole­
punched to allow the passage of the electrodes and allow them to lay flush against the 
rubber piece. Two electrodes were placed higher on the abdomen, the next two were 
positioned immediately posterior to the first two, and the fifth was the ground electrode 
that was located lower on the abdomen. 
Figure 3. Newborn rat pup with mini-electrodes used to generate the ECG. 
The wires were attached to the rat using an electrically conductive adhesive gel (Tac 
Gel), and wired back to the ECG. Gauze was gently wrapped around the rat to help maintain 
comfort while also keeping the electrodes in place. The ECG wires were connected to 
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channels 1 and 2 of an ETH-255 Bridge/Bio Amplifier (CB Sciences Inc., Dover, NH). The 
amplifier was set to have a gain of xlO. The low pass was set to 50 Hz while the high pass 
was set to 0.03 Hz. This amplifier was then connected to a PowerLab/200 (AD Instruments, 
Colorado Springs, CO). 
Using the Chart4 program, within PowerLab, two simultaneous ECG recordings 
were collected. By using the four recording electrodes a continuous recording could be 
obtained in case one set of electrodes lost contact during the testing period. The sampling 
rate was set to 1000 samples/sec, the range for each channel was set to 500 mV, and the 
digital filter for each channel was set to low pass 50 Hz with a cut off frequency at 54 Hz. 
The settings for both Chart4 and the PowerLab remained the same for each experiment. 
DRUG PREPARATION 
Both the theophylline and 8-cyclopenyltheophylline used in the experiment were 
obtained from the Sigma Chemical Co. (St. Louis, MO). In order to prepare for its 
administration, CPT was dissolved in a small amount of l M  sodium hydroxide and brought 
to volume with deionized water so that the resulting solutions were 64 µg/mL, 128 µg/mL, 
and 256 µg/mL. The pH was adjusted to about 8 with lM hydrochloric acid. The injection 
volume used was 5 µL/g of body weight, with the highest dose rats receiving a double 
volume (10 µL/g) of 256 µg/mL of CPT. The four injection doses of CPT used for this 
experiment were 320 µg/kg, 640 µg/kg, 1280 µg/kg, and 2560 µg/kg. The saline solution 
used as a control was 0.9% NaCl. A total of eight rats were used per dose of CPT and saline 
solution, resulting in a total of forty rats used for the CPT experiment. 
The same process was performed for the preparation and experimentation for 
theophylline. However, the doses of theophylline were increased to milligram amounts. 
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Theophylline was dissolved in a small amount of 1M sodium hydroxide and brought to 
volume with deionized water so that the resulting solutions were 2mg/mL, 4mg/mL, and 
Smg/mL with a 0.9% saline solution still being used as the control. The injection volume 
used was 5 µL/g of body weight, resulting in the injection doses of theophylline to be 10 
mg/kg, 20 mg/kg, and 40 mg/kg of body weight. A total of eight rats were used per dose of 
theophylline and saline solution, resulting in a total of 32 rats used for the theophylline 
experiment. In total, 72 rats were used in this experiment. The Institutional Animal Care 
and Use Committee at Eastern Illinois University approved the protocol (#06-011) for this 
experiment. 
PROCEDURE 
ECG electrodes were attached to an unanesthetized rat. The rat was wrapped in a 
small amount of gauze, and placed in a water-jacketed cylindrical tube heated to 35°C in 
order to maintain body temperature. The interior of the tube was Scm in diameter. During 
each experiment the environmental conditions such as noise level, light, temperature, etc. 
were kept constant. 
A 10-min pre-injection control ECG was recorded. After this initial recording, the rat 
was removed from the cylinder and injected subcutaneously near the base of the scalp 
using a 100µ1 glass syringe and a 26-ga needle with a randomly assigned dose of CPT or 
saline solution. This injection site was selected, as it was safe and easy location to 
administer the drug without disturbing the ECG electrodes or risking injury to vital organs. 
An injection was chosen as the best method to administer the drugs as opposed to an oral 
dose because of the young age of the rats, it was easier to control the dose, and the drug is 
absorbed more rapidly. 
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Immediately following injection the rat was placed back in the warming cylinder 
and the ECG was recorded. The heart rate was determined every 5 min during the 
continuous 60-min recording. After the 60 min of recording, the rats were returned to their 
mothers. Heart rate was determined using the timing of ten uninterrupted QRS complexes, 
specifically the larger more obvious R spike (Fig. 4). QRS complexes were selected from a 
section of the ECG where there was minimal movement from the rat. If there was 
movement during the desired time interval, it was necessary to shift the analysis time 
slightly to find 10 uninterrupted QRS complexes. The formula used to calculate heart rate 
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Figure 4. Consecutive QRS complexes generated by an ECG. 
For each of the 5-min time intervals, two heart rates were determined using time 
segments approximately 1 minute apart; the mean these two heart rates was then 
calculated. At each time point the heart rate was averaged for all eight rats of the same 




There were two methods used to analyze the data. The data were analyzed by two-
way analysis of variance (ANOVA) with repeated measures using Sigma Plot v l 1.2 (Sys tat 




Theophylline produced significant dose-related increases in heart rate over the 
range of 10 to 40 mg/kg (Fig. 5). The average (±SEM) pre-injection control heart rate for all 
theophylline treatment groups and saline was 342 ± 6 bpm. The average pre-injection 
heart rate ranged from 330 to 352 bpm for the different treatment groups (Fig. 5). To 
eliminate the impact of these differences, post-treatment data were normalized by 
computing percent change from pre-injection control: Percent change = 
Post-Treatment Heart Rate-Pre-Injection Heart Rate 
X lOO Pre-Injection Heart Rate 
The mean heart rate of saline-treated rats varied by less then 3% during the 60-
minute testing period (Fig. 6). There was no significant change in the saline control over 
time (Fig. 5) or percent change in heart rate data (Fig. 6). A two-way ANOVA with repeated 
measures showed that there was no treatment effect on heart rate (P=0.084, Table 1). 
Change over time was highly significant (P<0.001, Table 1) and there was a highly 
significant treatment versus time interaction over the 60-minute test period (P<0.001, 
Table 1). 
The pairwise comparison of each theophylline treatment dose to the saline control 
found that the largest dose, theophylline 40 mg/kg (THE040), had an effect on heart rate 
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(P=0.04, Holm-Sidak test), while theophylline 10 mg/kg (THEO 10) and 20 mg/kg (THEO 
20) treatments had no effect (P=0.51 and P= 0.46 respectively; Holm-Sidak method). In the 
THEO 40, it was observed that the subjects were more active than the other treatment 
groups or saline controls. 
In pairwise comparison of each treatment to the saline control with respect to time, 
there was an e ffect of time on each treatment. In fact, subjects exposed to the THEO 10, 
THEO 20, and THEO 40 treatments all had significantly different heart rates compared to 
pre-injection controls at every time interval over the 60-min time period (Holm-Sidak test, 
Fig. 4 ). When considering the treatment versus time interaction to compare each treatment 
with the saline control, it was determined that THEO 40 had an effect on heart rate from 
the 5 min to 40 min time intervals, while THEO 10 and THEO 20 showed no dif ference at 
any time intervals over the 60-min testing period. 
There was a highly significant theophylline treatment effect on the percent change 
in heart rate (P<0.001, Table 2). Time was also found to have an effect on the percent 
change in heart rate (P < 0.001, Table 2). Also, when examining at the treatments over time, 
there was a significant interaction on percent change in heart rate (P <0.001, Table 1). 
When using the pairwise comparison of each theophylline treatment dose to saline, 
it was found that each treatment was different from the saline control (Fig. 5). When 
comparing the treatments to saline, there was significance at each time interval throughout 
the 60-min testing period (Fig. 5). Theophylline had its peak effects on the subjects' heart 
rate at 20 - 30 min after injection. 
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While there was a trend toward increasing heart rate with CPT, there was not a 
clear dose-response relationship in the range of the selected doses, 320 to 2560 µg/kg. The 
average pre-injection heart rate for all CPT treatment groups and saline was 343 (± 5) bpm. 
The average pre-injection heart rate ranged from 335 to 360 bpm for the different 
treatment groups (Fig. 7). To eliminate the impact of these differences, post-treatment data 
were normalized by computing the percent change from pre-injection controls using the 
same equation as the theophylline trials. 
It was observed that the saline control heart rate did fluctuate more during the CPT 
trials (Fig. 8) than the during the theophylline trials (Fig. 6). Still, the average heart rate of 
saline-treated rats varied by less then 3% during the 60 min testing period and none of the 
saline values were statistically significant (Fig. 8). 
Two-way ANOVA with repeated measures showed that the selected CPT treatment 
doses did not produce any significant change in heart rate (P=0.43, Table 3). Time had a 
significant effect on the heart rates over the 60-mim testing period (P<0.001, Table 3). 
There was no significance to the interaction between treatment and time interaction over 
the 60-min testing period (P=0.16, Table 3). 
The pairwise comparison of each CPT treatment dose to the saline controls revealed 
that none of the treatment doses produced any effect on heart rate. Time was the only 
factor that appeared to influence heart rate, starting at the15-min time interval through the 
remainder of the testing period. In the pairwise comparison of each CPT treatment to 
subjects exposed to the saline treatment in respect to time, only the highest treatment 
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dose, CPT 2S60 was influenced by elapsed time, from the 2S-min time interval through the 
duration of the testing period (Holm-Sidak method, Fig. 6). 
Data representing the percent change in heart rate in CPT-treated rats revealed a 
pattern similar to that of the heart rate data. Unlike theophylline, CPT treatment doses had 
no significant effect on heart rate (P = 0.42, Table 4). The interaction of treatments over 
time did not produce a change in heart rate (P=0.204, Table 4). Only time was found to 
have a significant effect on the percent change in heart rate (P<0.001, table 4). 
When using the pairwise comparison of the four treatments doses of CPT to saline, it 
was found that none of the CPT doses exerted any influence on the heart rate of the tested 
subjects. Unlike theophylline, the effects of CPT slowly increased throughout the testing 
period with its peak effects from SS to 60 minutes. In fact, when analyzing the interaction 
between the dose treatment over time (Fig. 9), only the highest treatment dose, CPT 2S60 
exhibited a significant interaction on the heart rate at the SO-min and SS-min time 
intervals. 
DISCUSSION 
The use of the methylxanthine drugs caffeine and theophylline are used to eliminate 
the effects of neonatal apnea (Aranda et al., 1986; Brouillette et al., 1990; Schmidt et al., 
2007). The negative side effects of these drugs include: increase in heart rate, increase 
oxygen consumption leading to inhibition of growth (Schmidt et al., 2006), headache, 
palpitations, dizziness, nausea, restlessness, agitation, and tachycardia. Furthermore, it is 
not understood if methylxanthine drugs have long-term effects (Schmidt et al., 2007). It 
would be beneficial to develop a xanthine drug that stimulates respiration but has fewer 
side effects. 
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An ECG was chosen as the best method to observe the electrical activity of the heart. 
This proved to be a challenge with unanesthetized newborn rats due to their small size and 
also their constant movement. To increase the chances of obtaining a successful ECG the 
number of recording electrodes was increased from two to four to ensure that if one set of 
electrodes were to lose contact, the remaining set would still be able to collect a recording. 
This proved to generate more successful results. 
For this study, theophylline was used as it is currently being administered in the 
treatment of apnea; at these dosages it stimulate respiration in infants (Aranda et al., 1986) 
and newborn rats (McGilliard et al., 1991). In contrast, CPT was selected for its high 
potency to antagonize adenosine A1 receptors (approximately 500 times more potent than 
theophylline; Shamim et al., 1989) and its ability to stimulate respiration (approximately 
60 times more potent than theophylline; Albers & McGilliard, 2012). Because of the 
increased potency of CPT it was not necessary to administer large doses in order to affect 
the response in respiratory rate (Albers & McGilliard, 2012). It was necessary, however, to 
increase the dose of theophylline in comparison to CPT in order to obtain a respiratory 
response (McGilliard et al., 1991); it was predicted that a similar dose range would be 
needed to stimulate heart rate. 
The addition of the cyclopentyl group to the 8-position on theophylline (Fig. 2) can 
increase the potency of the xanthine analogs (Shamim et al. 1989). Another highly potent 
adenosine A1 receptor antagonist that was studied in our laboratory is 8-cyclopentyl-1,3-
dipropylxanthine (DPCPX) which substitutes propyl groups for the methyl groups of CPT. 
Both of these xanthine analogs have a similar affinity for adenosine A2 receptors; however, 
DPCPX has a much higher affinity for A1 receptors than CPT (Table 5, Shamim et al., 1989). 
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DPCPX at 320µg/kg produced a 35 % increase in heart rate in neonatal rats (Cassidy and 
McGilliard, 2010). It may be that CPT's antagonism of adenosine Az receptors tested 
diminished some of the cardiostimulant effect produced at Ai receptors. 
When compared to CPT in the selected dose ranges, theophylline showed a more 
significant increase in heart rate, with the most notable difference in the THEO 40 
treatment. What was unexpected with subcutaneous injection of theophylline was the 
sudden increase from the control heart rates within 5 min after injection. This increase was 
not seen in the saline control, suggesting that it was not due caused by the stress of 
handling and injection (Fig 5). In the CPT treatments, there was a more gradual incline and 
only the highest dose showed increases in bpm over pre-injection control after 5 min (Fig 
7). The difference in timing between the two drugs could be caused by variability in the 
absorption and solubility of the two drugs. Both drugs have low solubility but theophylline 
is more soluble than CPT. Theophylline administered in liquid form is absorbed readily and 
completely (Undem, 2006), while the absorption abilities of CPT have not been explored. 
The solubility of methylxanthines can be enhanced by the formation of complexes such as 
ethylenediamine theophylline (Undem, 2006). 
In previous studies concerning respiration in newborn rats, both theophylline and 
CPT had peak effects around 20-30 min after injection and effects slowly declined 
thereafter (Albers & McGilliard, 2012; McGilliard et. al. 1991). The same time course was 
observed for theophylline, but not for CPT in the present study, as theophylline produced 
the highest heart rates the 20- to 30-min mark, with the most significant change being a 
15.5% increase in heart rate after administration of THEO 40 (Fig. 6). Around the 40-min 
interval, and through the rest of the testing period, it became increasingly difficult to 
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analyze the beats on the ECG for many of the THEO 40 pups. Around this time, the rat pups 
became much more active and were in constant motion. Despite the increase in activity, 
there was a steady decline seen in the THEO 40 slope, more so than any of the other 
theophylline doses (Fig. 5). Theophylline excites the central nervous system at all levels 
(Rall, 1990). With the increase in nervous stimulation, it would be expected to see 
excitation at higher methylxanthine doses. This irritability response was not seen with any 
of the CPT doses. 
Unlike theophylline, CPT did not increase the heart rate. The greatest change was 
observed between 50 and 60 min after injection of the highest dose CPT 2560 with a 12% 
increase over control (Fig. 8). These results, as well as a smaller increase in heart rate (but 
similar time course) are consistent with the research of Workman and McGilliard (2012). 
The remaining CPT treatments were found to have no effect on the heart rate. Although 
subjects exposed to CPT 320 appear to experience an increased heart rate, the curve 
change over time was not statistically significant, except for 55 and 60-min time points 
where the percent change reached 8%. 
The overall hope is to find a drug that will assist with respiration without the 
negative side effect of cardiostimulation. Albers & McGiliard (2012) suggested that the 8-
cyclopentyl substitutions produce a potent drug that stimulates respiration. In the present 
study, as well as that of Workman and McGilliard (2012), it appears that there is no 
significant effect of CPT on the heart rate. There is evidence to suggest that CPT 2560 may 
produce some cardiostimulation. It is evident that 8-cyclopentyl substitutions to 
theophylline are responsible for increasing respiration more than heart rate and results 
like this one could be helpful in understanding the antagonism of adenosine Ai receptors as 
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opposed to adenosine Az receptors. Higher doses of CPT need to be tested in order to 
determine whether or not administration of CPT leads to an increase in heart rate. 
However, the low solubility of this drug makes it difficult to increase the dosage levels 
beyond those used in my study. 
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Table 1. Two-way AN OVA with repeated measures of theophylline heart rates. 
Source of Variation DF SS MS F p 
Treatment 3 109269 36423 2.45 0.084 
Rat (Treatment) 28 416433 14873 
Time 12 26619 2218 30.32 <0.001 
Treatment x Time 36 11020 306 4.18 <0.001 
Residual 336 24586 73 
Total 415 587926 1417 
Table 2. Two-way AN  OVA with repeated measures of theophylline percent change in heart 
rate. 
Source of Variation DF SS MS F p 
Treatment 3 6785 2262 37.89 <0.001 
Rat (Treatment) 28 60 
Time 11 422 38 5.79 <0.001 
Treatment x Time 33 437 13 2.00 0.001 
Residual 308 2040 7 
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Figure 6. Percent change in heart rate of neonatal rats over time with varying doses of 
theophylline. 
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Table 3. Two-way AN OVA with repeated measures of CPT heart rates. 
Source of Variation DF SS MS F p 
Treatment 4 52791 13198 0.99 0.428 
Rat (Treatment) 35 468354 13382 
Time 12 22376 1865 8.13 <0.001 
Treatment x Time 48 13421 280 1.22 0.159 
Residual 420 96365 229 
Total 519 653307 1259 
Table 4. Two-way AN OVA with repeated measures of CPT percent change in heart rates. 
Source of Variation DF SS MS F p 
Treatment 4 288 707 1.00 0.421 
Rate (Treatment) 35 24765 708 
Time 11 1414 129 7.27 <0.001 
Treatment x Time 44 923 21 1.19 0.204 
Residual 385 6812 18 
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Figure 8. Percent change in heart rates of neonatal rats over time with varying does of 8-
cyclopentyltheophylline (CPT). 
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Table 5. Comparison between affinity of xanthine analogs at adenosine Al and A2 receptors 
(Shamim et al., 1989). 
Xanthine Ai Az 
Ratio 
Az/A1 
1,3-dimethylxanthine (Theophylline) 13 (11-15) 14(4-18) 1.1 
8-cyclopentyltheophylline (CPT) 0.024 (0.017 - 0.034) 0.14 (0.14-0.15) 5.8 
8-cyclopentyl-1,3-dipropylxanthine 0.0009 (0.0008-
0.14 (0.12-0.17) 160 
(DPCPX) 0.0011) 
